Latest filing published 29 Mar 2024 for AN2 Therapeutics, Inc..
Insider track record
No signal scores available.
Paul Eckburg: trading record in brief
This profile gathers the share dealings of Paul Eckburg in AN2 Therapeutics, Inc. Altogether 2 filings, all relating to 15 March 2024.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 29 March 2024, reports a share grant in AN2 Therapeutics, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Paul Eckburg
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 30,000 shares0Common StockSEC:0001610717-24-000196:0
- 30,000 shares0CommonSEC:0001610717-24-000165:0
2 of 2 declarations
